Aliaa Fouad

6PUBLICATIONS
12CO-AUTHORS
Medical bacteriologyMedical infection agents (incl. prions)PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 27, 2025
Efficacy of human-simulated aztreonam-avibactam against Stenotrophomonas maltophilia in the neutropenic murine thigh infection model.

Yakun Fu, Aliaa Fouad, Hanna F Roenfanz

|Oct 23, 2025
In vitro persistence of clinical methicillin-resistant Staphylococcus aureus isolates from bone and joint infections after exposure to daptomycin, telavancin, and vancomycin.

Aliaa Fouad, Joseph L Kuti, Christian M Gill

|May 15, 2025
Pharmacokinetic and pharmacodynamic evaluation of sulbactam-durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex.

Wesley D Kufel, Nabil Zeineddine, Aliaa Fouad

|May 05, 2025
Ex vivo assessment and simulation to guide cefepime-taniborbactam dosing recommendations for patients receiving continuous renal replacement therapy.

Aliaa Fouad, Cole McGrath, Ecem Buyukyanbolu

|Apr 03, 2025
Activity of novel ceftibuten-avibactam, ceftazidime-avibactam, and comparators against a challenge set of Enterobacterales from outpatient centers and nursing homes across the United States (2022-2024).

Aliaa Fouad, April M Bobenchik, Robin Chamberland

|May 07, 2024
Comparison of BD Phoenix and disk diffusion to broth microdilution for determining cefepime susceptibility among carbapenem-resistant Enterobacterales.

Aliaa Fouad, Patricia J Simner, David P Nicolau

Pageof 1

Frequent Collaborators

2 joint publications

David P Nicolau

2 joint publications

Tomefa E Asempa

2 joint publications

Joseph L Kuti

1 joint publications

Patricia J Simner